Skip to main navigation Skip to search Skip to main content

Aging, telomeres and heart failure

  • Liza S.M. Wong
  • , Pim Van Der Harst*
  • , Rudolf A. De Boer
  • , Jardi Huzen
  • , Wiek H. Van Gilst
  • , Dirk J. Van Veldhuisen
  • *Corresponding author for this work
  • University Medical Centre Groningen

Research output: Contribution to journalReview articlePopular

60 Citations (Scopus)

Abstract

During normal aging, the heart undergoes functional, morphological and cellular changes. Although aging per se does not lead to the expression of heart failure, it is likely that age-associated changes lower the threshold for the manifestation of signs and symptoms of heart failure. In patients, the susceptibility, age of onset and pace of progression of heart failure are highly variable. The presence of conventional risk factors cannot completely explain this variability. Accumulation of DNA damage and telomere attrition results in an increase in cellular senescence and apoptosis, resulting in a decrease in the number and function of cells, contributing to the overall tissue and organ dysfunction. Biological aging, characterized by reduced telomere length, provides an explanation for the highly interindividual variable threshold to express the clinical syndrome of heart failure at some stage during life. In this review, we will elaborate on the current knowledge of aging of the heart, telomere biology and its potential role in the development of heart failure.

Original languageEnglish
Pages (from-to)479-486
Number of pages8
JournalHeart Failure Reviews
Volume15
Issue number5
DOIs
Publication statusPublished - Sept 2010
Externally publishedYes

Fingerprint

Dive into the research topics of 'Aging, telomeres and heart failure'. Together they form a unique fingerprint.

Cite this